Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.8.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported in the Consolidated Balance Sheet to the total of the amounts in the Consolidated Statement of Cash Flows as of March 31, 2018, December 31, 2017, March 31, 2017 and December 31, 2016.

 

(Dollars in thousands)   March 31,
2018
    Dec. 31,
2017
    March 31, 
2017
    Dec. 31, 
2016
 
Cash and cash equivalents   $ 4,263     $ 7,307     $ 15,835     $ 4,105  
                                 
Restricted cash included in current/long term assets     692       691       691       692  
                                 
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 4,955     $ 7,998     $ 16,526     $ 4,797  

Schedule of Antidilutive Securities

The following schedule details the number of shares issuable upon the exercise of stock options, warrants and conversion of preferred stock, which have been excluded from the diluted loss per share calculation as the inclusion would be anti-dilutive for the three months ended March 31, 2018 and 2017:

 

    2018     2017  
Stock options     11,614       10,326  
                 
Preferred Stock issuable upon conversion     14,729       15,900  
                 
Warrants     5,958       6,373  
                 
Total     32,301       32,599